Evidence map›Paper›PMID 29380153›Full record

ArticleJournal of industrial microbiology & biotechnology2018

Rational design of a synthetic Entner-Doudoroff pathway for enhancing glucose transformation to isobutanol in Escherichia coli.

Shaoxiong Liang, Hong Chen, Jiao Liu, Jianping Wen

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of industrial microbiology & biotechnology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. EngineeringMicroorganisms · 2023
    Article
  6. Article
  7. System metabolic engineering ofFrontiers in bioengineering and biotechnology · 2023
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Synthetic Biology and Metabolic Engineering EmployingFrontiers in bioengineering and biotechnology · 2020
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Shaoxiong LiangKey Laboratory of Systems Bioengineering (Ministry of Education), Tianjin University, Tianjin, 300072, People's Republic of China.
Hong ChenKey Laboratory of Systems Bioengineering (Ministry of Education), Tianjin University, Tianjin, 300072, People's Republic of China.
Jiao LiuKey Laboratory of Systems Bioengineering (Ministry of Education), Tianjin University, Tianjin, 300072, People's Republic of China.
Jianping WenKey Laboratory of Systems Bioengineering (Ministry of Education), Tianjin University, Tianjin, 300072, People's Republic of China. jpwen@tju.edu.cn.
Tianjin University · CNCollaborative Innovation Center of Chemical Science and Engineering Tianjin · CN

Funding

the Key Program of National Natural Science Foundation of China 21236005the key technologies R & D program of Tianjin 16YFZCSY00780the National 973 Project of China 2013CB733600the National Natural Science Foundation of China 20976124the National Natural Science Foundation of China 21376171
6 · The paper itself

Abstract

Isobutanol as a more desirable biofuel has attracted much attention. In our previous work, an isobutanol-producing strain Escherichia coli LA09 had been obtained by rational redox status improvement under guidance of the genome-scale metabolic model. However, the low transformation from sugar to isobutanol is a limiting factor for isobutanol production by E. coli LA09. In this study, the intracellular metabolic profiles of the isobutanol-producing E. coli LA09 with different initial glucose concentrations were investigated and the metabolic reaction of fructose 6-phosphate to 1, 6-diphosphate fructose in glycolytic pathway was identified as the rate-limiting step of glucose transformation. Thus, redesigned carbon catabolism was implemented by altering flux of sugar metabolism. Here, the heterologous Entner-Doudoroff (ED) pathway from Zymomonas mobilis was constructed, and the adaptation of upper and lower parts of ED pathway was further improved with artificial promoters to alleviate the accumulation of toxic intermediate metabolite 2-keto-3-deoxy-6-phospho-gluconate (KDPG). Finally, the best isobutanol-producing E. coli ED02 with higher glucose transformation and isobutanol production was obtained. In the fermentation of strain E. coli ED02 with 45 g/L initial glucose, the isobutanol titer, yield and average producing rate were, respectively, increased by 56.8, 47.4 and 88.1% to 13.67 g/L, 0.50 C-mol/C-mol and 0.456 g/(L × h) in a shorter time of 30 h, compared with that of the starting strain E. coli LA09.

Indexed as

FermentationGlycolysisBiomassButanolsCarbonChemistry, PharmaceuticalChromatography, High Pressure LiquidCulture MediaEscherichia coliEscherichia coli ProteinsGas Chromatography-Mass SpectrometryGlucoseIndustrial MicrobiologyMicroorganisms, Genetically-ModifiedMultivariate AnalysisNADPButanolsCarbonCulture MediaEscherichia coli ProteinsGlucoseisobutyl alcoholNADPEscherichia coliGlucose transformationHeterologous ED pathwayIsobutanolMetabolic profiles

Identifiers

PMID29380153
OpenAlexW2794196137

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.